CTOs on the Move

Cellenkos Incorporated

www.cellenkosinc.com

 
Cellenkos is an early stage clinical biotechnology company that focuses on cord blood-derived T-regulatory cellular therapies for the treatment of autoimmune diseases and inflammatory conditions. Cellenkos is founded on the technologies arising from the laboratory investigations of Simrit Parmar, M.D. Cellenkos` lead product CK0801 delivers clinically meaningful doses of allogeneic cord blood T-regulatory cells to overcome immune dysfunction.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Elizabeth Read
 Chief Technology Officer Profile

Funding

Cellenkos Incorporated raised $15M on 11/04/2021

Similar Companies

Simplifihca

Enchanted Rock State Natural Area

Orthomerica

We are a developer, manufacturer and marketer of prefabricated, semi-custom and custom orthoses. Orthomerica is known for providing exceptional customer service, quality, innovation and prompt delivery of orthopaedic braces to the orthotics and

Avamere

Avamere Family of Companies, a group of independent privately owned post-acute care companies, is dedicated to seniors` health and well-being. We take great pride in offering a continuum of care, which allows seniors to stay independent and active.

Ciel Senior Living

Ciel Senior Living is a company that offers Assisted Living and Memory Care services in Long Grove, Illinois.